ArriVent BioPharma Inc
ArriVent BioPharma Inc (AVBP) Option Chain
As of September 21, 2026, ArriVent BioPharma Inc is trading at $30.47, a +2.46% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 132.5%. IV Rank is 43%.
Read more
Tracking the AVBP option chain helps you see every strike and expiry on ArriVent BioPharma Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. ArriVent BioPharma Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AVBP options activity at a glance. Use our scanner to monitor the AVBP option chain in real time and filter for the AVBP options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AVBP stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the AVBP option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where AVBP stock options are being actively traded and where they are not.
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc.
The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls ArriVent BioPharma Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen AVBP options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of AVBP stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile58.33% Neutral
- Market cap (M$)1,466
- 52 weeks high-17.00%
- 52 weeks low74.94%
- Analyst recommendationStrong Buy
1.00 - Target price$44.91
47.39% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-16
- P/E—
- Future P/E—
- EPS (ttm)-3.68
- EPS growth next 5 years23.74%
As of September 21, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 33.12 | 1,451 | 190 | 0.88 | 7.97 | 6.70 | 11.00 | 22.50 | -22.15 | 0.45 | 4.90 | 0.00 | 2.68 | 18 | 8 | 66.88 |
| 43.17 | 8,958 | 190 | 1.73 | 5.47 | 5.20 | 9.20 | 25.00 | -13.49 | 0.95 | 4.90 | 0.00 | 2.93 | 82 | 423 | 56.83 |
| 61.24 | 588 | 4 | 3.88 | 0.47 | 2.20 | 6.50 | 30.00 | +3.81 | 3.00 | 7.00 | 0.00 | 5.00 | 150 | 102 | 38.76 |
| 74.94 | 805 | 1 | 2.70 | 0.00 | 0.70 | 4.70 | 35.00 | +21.11 | 6.00 | 10.50 | 4.53 | 3.72 | 0 | 11 | 25.06 |
| 84.32 | 1,450 | 20 | 3.20 | 0.00 | — | 3.20 | 40.00 | +38.41 | 10.50 | 14.90 | 9.53 | 3.17 | 0 | 44 | 15.68 |
As of September 21, 2026
Scan the full option chain in one place
Browse the full AVBP option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→